Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lusutrombopag in Recurrent/Refractory/Intolerable NSAA
NCT06426043Phase 4Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jun 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lusutrombopag in aplastic anemia, sponsored by Peking Union Medical College Hospital. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
lusutrombopag
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT06426043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06426043.